1. Expert Recommendations for First-Line Management of Metastatic Renal Cell Carcinoma in Special Subpopulations

   • Javier Puente
   • Xavier García del Muro
   • Cristina Suárez

   Review Article 26 December 2015 Pages: 129 - 141

   

2. Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis

   • Roberto Iacovelli
   • Franco Nolè
   • Camillo Porta

   Systematic Review 02 October 2015 Pages: 143 - 148

   

3. First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors

   • Rodrigo Dienstmann
   • Ulrik Lassen
   • Josep Tabernero

   Original Research Article 27 August 2015 Pages: 149 - 156

   

4. Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study

   • S. Vatrano
   • L. Righi
   • S. Novello

   Original Research Article 28 August 2015 Pages: 157 - 166

   

5. Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study

   • J. B. Auliac
   • C. Fournier
   • R. Gervais

   Original Research 29 August 2015 Pages: 167 - 174

   

6. Early Tumor Shrinkage Under Treatment with First-line Tyrosine Kinase Inhibitors as a Predictor of Overall Survival in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Multi-Institutional Study in Japan

   • Hideaki Miyake
   • Akira Miyazaki
   • Masato Fujisawa

   Original Research Article 04 September 2015 Pages: 175 - 182

   

7. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy

   • Daniela Laura Papademetrio
   • Silvina Laura Lompardía
   • Élida Álvarez

   Original Research Article 16 September 2015 Pages: 183 - 195

   

8. RETRACTED ARTICLE: MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8

   • Ying Wang
   • Po Xu
   • Shegan Gao

   Original Research Article 26 September 2015 Pages: 197 - 207

   

9. Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN)

   • S S Islam
   • R B Mokhtari
   • W A Farhat

   Original Research 10 October 2015 Pages: 209 - 227

   

10. Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib

    • Ying Chen
    • Brian I. Rini
    • Yazdi K. Pithavala

    Short Communication 24 September 2015 Pages: 229 - 234

    

11. Vemurafenib-induced progression of breast cancer: a case report and review of the literature

    • Aleksei V. Novik
    • Svetlana A. Protsenko
    • Evgeny N. Imyanitov

    Therapy in Practice 12 August 2015 Pages: 235 - 238

    

12. Sonidegib: A Review in Locally Advanced Basal Cell Carcinoma

    • Celeste B. Burness
    • Lesley J. Scott

    Adis Drug Evaluation 12 February 2016 Pages: 239 - 246

    

13. Dinutuximab: A Review in High-Risk Neuroblastoma

    • Sheridan M. Hoy

    Adis Drug Evaluation 19 February 2016 Pages: 247 - 253

    

14. Carfilzomib Triple Combination Therapy: A Review in Relapsed Multiple Myeloma

    • Sheridan M. Hoy

    Adis Drug Evaluation 14 March 2016 Pages: 255 - 262